WO2001005414A8 - Algae protein polysaccharide extraction and use thereof - Google Patents

Algae protein polysaccharide extraction and use thereof

Info

Publication number
WO2001005414A8
WO2001005414A8 PCT/CN2000/000205 CN0000205W WO0105414A8 WO 2001005414 A8 WO2001005414 A8 WO 2001005414A8 CN 0000205 W CN0000205 W CN 0000205W WO 0105414 A8 WO0105414 A8 WO 0105414A8
Authority
WO
WIPO (PCT)
Prior art keywords
protein polysaccharide
algae protein
polysaccharide extraction
algae
extraction
Prior art date
Application number
PCT/CN2000/000205
Other languages
French (fr)
Chinese (zh)
Other versions
WO2001005414A1 (en
Inventor
Qing Qi
Jian Ding
Original Assignee
Qing Qi
Jian Ding
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qing Qi, Jian Ding filed Critical Qing Qi
Priority to US10/031,520 priority Critical patent/US6893642B1/en
Priority to JP2001510468A priority patent/JP4023717B2/en
Priority to DE60045894T priority patent/DE60045894D1/en
Priority to AT00945521T priority patent/ATE506956T1/en
Priority to AU59613/00A priority patent/AU5961300A/en
Priority to EP00945521A priority patent/EP1197218B1/en
Publication of WO2001005414A1 publication Critical patent/WO2001005414A1/en
Publication of WO2001005414A8 publication Critical patent/WO2001005414A8/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/946—Microorganisms using algae

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention provides a pharmaceutical composition containing algae protein polysaccharide extracts, and a method for preparing algae protein polysaccharide extracts.
PCT/CN2000/000205 1999-07-19 2000-07-19 Algae protein polysaccharide extraction and use thereof WO2001005414A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US10/031,520 US6893642B1 (en) 1999-07-19 2000-07-19 Algae protein polysaccharide extraction and use thereof
JP2001510468A JP4023717B2 (en) 1999-07-19 2000-07-19 Spirulina proteoglycan extract and method of use
DE60045894T DE60045894D1 (en) 1999-07-19 2000-07-19 EXTRACTION OF POLYSACCHARIDE FROM ALGAE PROTEIN AND USE THEREOF
AT00945521T ATE506956T1 (en) 1999-07-19 2000-07-19 EXTRACTION OF POLYSACCHARIDES FROM ALGAE PROTEIN AND USE THEREOF
AU59613/00A AU5961300A (en) 1999-07-19 2000-07-19 Algae protein polysaccharide extraction and use thereof
EP00945521A EP1197218B1 (en) 1999-07-19 2000-07-19 Algae protein polysaccharide extraction and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN99109881A CN1098707C (en) 1999-07-19 1999-07-19 Medicinal composition containing algal protein polyose extract and extraction of algal protein polyose
CN99109881.1 1999-07-19

Publications (2)

Publication Number Publication Date
WO2001005414A1 WO2001005414A1 (en) 2001-01-25
WO2001005414A8 true WO2001005414A8 (en) 2001-06-28

Family

ID=5274217

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2000/000205 WO2001005414A1 (en) 1999-07-19 2000-07-19 Algae protein polysaccharide extraction and use thereof

Country Status (9)

Country Link
US (1) US6893642B1 (en)
EP (1) EP1197218B1 (en)
JP (1) JP4023717B2 (en)
CN (1) CN1098707C (en)
AT (1) ATE506956T1 (en)
AU (1) AU5961300A (en)
DE (1) DE60045894D1 (en)
ES (1) ES2365319T3 (en)
WO (1) WO2001005414A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080124318A1 (en) * 2006-11-28 2008-05-29 Jerold Lisson Algae supplement and treatment method
US20080124286A1 (en) * 2006-11-28 2008-05-29 Lisson Jerold B Algae supplement and treatment method
CN102020705B (en) * 2009-09-15 2012-08-15 长江大学 Method for preparing spirulina protein isolate
CA2793695A1 (en) * 2010-04-06 2011-10-13 Heliae Development, Llc Selective extraction of proteins from freshwater algae
TWI414362B (en) 2011-05-18 2013-11-11 Ind Tech Res Inst Extraction apparatus
CN104351752B (en) * 2014-09-19 2017-07-18 南京农业大学 It is a kind of from edible mushroom marine alga GL-PP compound functional capsule product production method
CN110507675A (en) * 2016-01-20 2019-11-29 齐清 Composition and application thereof comprising algae protein polyose extract
JP7166578B2 (en) * 2017-07-18 2022-11-08 国立大学法人 和歌山大学 antiviral agent
JP7131937B2 (en) * 2018-03-28 2022-09-06 森永乳業株式会社 Spirulina-containing green beverage and method for producing the same
WO2023135950A1 (en) * 2022-01-11 2023-07-20 一丸ファルコス株式会社 Proteoglycan-containing immune response modifier

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58128322A (en) * 1982-01-27 1983-07-30 Kurorera Kogyo Kk Carcinostatic agent
JPS6466126A (en) * 1987-09-07 1989-03-13 Lion Corp Antitumor agent
JPH06263649A (en) * 1993-01-13 1994-09-20 Maruha Corp Immunopotenitator
JP3020387B2 (en) * 1993-07-27 2000-03-15 日石三菱株式会社 Antiviral substance
JP3403496B2 (en) * 1993-09-24 2003-05-06 株式会社ヤクルト本社 Anti-ulcer agent and Helicobacter pylori colonization inhibitor
CN1036067C (en) * 1994-08-24 1997-10-08 沈阳医药工业研究所 Method for extracting protein and polysaccharide from spiral algae and its use
CN1064969C (en) 1994-08-31 2001-04-25 张媛贞 Obtusatus arthrospira phycocyanin and its application
CN1130028A (en) 1995-02-27 1996-09-04 陈志龙 Method for preparing phycocyan
JPH09176022A (en) * 1995-12-26 1997-07-08 Dainippon Ink & Chem Inc Metastasis inhibitor
JPH09176002A (en) * 1995-12-27 1997-07-08 Kureha Chem Ind Co Ltd Gingerol-containing agent for suppressing synthesis of protein of hsp27 family
CN1119946C (en) * 1997-11-27 2003-09-03 中国科学院水生生物研究所 Extracting method for nutritive component of spirulina

Also Published As

Publication number Publication date
CN1098707C (en) 2003-01-15
AU5961300A (en) 2001-02-05
JP2003504410A (en) 2003-02-04
EP1197218B1 (en) 2011-04-27
EP1197218A1 (en) 2002-04-17
ATE506956T1 (en) 2011-05-15
US6893642B1 (en) 2005-05-17
ES2365319T3 (en) 2011-09-29
EP1197218A4 (en) 2004-06-09
JP4023717B2 (en) 2007-12-19
CN1280855A (en) 2001-01-24
DE60045894D1 (en) 2011-06-09
WO2001005414A1 (en) 2001-01-25

Similar Documents

Publication Publication Date Title
ZA200407868B (en) 17alpha-Alkyl-17beta-oxy-estratrienes, uses thereof and pharmaceutical preparations.
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
AU4048299A (en) Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same
HK1044945A1 (en) 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use.
AU2001240753A1 (en) Lipid nanocapsules, preparation method and use as medicine
IL150225A0 (en) Lipopeptides, pharmaceutical compositions containing the same and methods for the production thereof
HK1047584A1 (en) Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process.
HK1042245A1 (en) Pharmaceutical moxifloxacin preparation.
MXPA03000579A (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same.
HK1019757A1 (en) Synthetic polysaccharides, preparation method therefor and pharmaceutical compositions containing same.
ZA200109602B (en) Purine derivatives, preparation method and pharmaceutical compositions containing same.
AU3156600A (en) Novel epothilon derivatives, method for the production thereof and their pharmaceutical application
MXPA01008148A (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals.
ZA99355B (en) Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them.
ZA200110150B (en) Streptogramin derivatives, preparation and compositions containing them.
WO2001005414A8 (en) Algae protein polysaccharide extraction and use thereof
ZA200203294B (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them.
HK1051003A1 (en) Ciclesonide-containing aqueous pharmaceutical composition.
AU3825700A (en) Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
HK1042092A1 (en) Novel morpholine derivatives, method for the prod uction thereof and pharmaceutical preparations containing said derivatives.
AP2003002874A0 (en) Echinocandin derivatives, preparation method and application as anti-fungal agents.
AU2001254812A1 (en) 9-oxa-epothilon derivatives, method for the production and use thereof in pharmaceutical preparations
ZA200002546B (en) Sorbate-preserved compositions, method for the manufacture thereof and their use.
HK1047037A1 (en) Pharmaceutical preparations containing nanosols ofchitosan, and their preparation.
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

WRT Later publication of a revised version of an international search report translation
WWE Wipo information: entry into national phase

Ref document number: 10031520

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2000945521

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000945521

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642